Technology

Nightingale’s internationally recognized biomarker analysis technology utilizes NMR (nuclear magnetic resonance) and an in-house developed quantification software to study and predict chronic diseases.

The leading approach to assess metabolic health

Our NMR-based technology provides a fine-grained snapshot of systemic metabolism and disease effects, measuring biomarkers from multiple pathways from one sample, in a single experiment.

High-throughput

Fast analysis even for the largest sample collections.

Low cost

Large coverage of biomarkers for an affordable price.

Consistent results

Sample preparation is minimal, resulting in comparable results between batches.

Accurate and precise

NMR-technology, our standard operating procedures and QMS all contribute to ensuring precise, repeatable and reproducible results.

Quality indicators

The intrinsic quality biomarkers in our blood panel can be identified to reveal samples of compromised quality.

Fully quantitative data

Biomarker measures provided in an easy-to-interpret format, in absolute concentrations (mmol/l, g/l and biologically meaningful ratios).

From research to clinics

Being used to analyse samples for leading research initiatives and healthcare settings, our technology is narrowing the gap between science and clinical use.

How it works

Nightingale’s technology is both affordable and scalable, accommodating any number of samples and providing fast delivery times. The platform handles every step of the process, from blood sample analysis to health data delivery.

Step 1

Each sample is tagged for identification.

Step 2

Minimal sample preparation, only buffer added.

Step 3

The NMR instrument scans the samples in a non-destructive way.

Step 4

NMR data is transformed into biomarkers of absolute concentrations.

Step 5

Results ready for analysis and interpretation.

Ensuring quality data

Nightingale is committed to achieving high quality in all its services. Quality and compliance with all applicable regulatory and customer requirements underline all our operations.

Certified quality management system

Nightingale Health operates under a certified quality management system in accordance with EN ISO 13485:2016 (certified by Dekra).

Certified quality management system

Nightingale Health operates under a certified quality management system in accordance with EN ISO 13485:2016 (certified by Dekra).

CE-marked technology

Nightingale measures all samples with a CE-marked IVD device.

CE-marked technology

Nightingale measures all samples with a CE-marked IVD device.

External Quality Assurance

Nightingale Health participates in UK NEQAS and WEQAS programs to monitor its measurement quality between Nightingale and other laboratories.

External Quality Assurance

Nightingale Health participates in UK NEQAS and WEQAS programs to monitor its measurement quality between Nightingale and other laboratories.

Healthcare quality

Procedures for clinical laboratory tests are in accordance with standard for medical laboratories (EN ISO 15189). Products intended for clinical use offered by Nightingale are calibrated to standard materials provided by National Institute of Standards and Technology (NIST). Method validation is done according to CLIA’s US FDA recognised consensus standards. Validated biomarkers: creatinine, glucose, cholesterol, HDL-C, LDL-C, triglycerides, ApoA1 and ApoB.

Healthcare quality

Procedures for clinical laboratory tests are in accordance with standard for medical laboratories (EN ISO 15189). Products intended for clinical use offered by Nightingale are calibrated to standard materials provided by National Institute of Standards and Technology (NIST). Method validation is done according to CLIA’s US FDA recognised consensus standards. Validated biomarkers: creatinine, glucose, cholesterol, HDL-C, LDL-C, triglycerides, ApoA1 and ApoB.

Contact

Whether you have a question or you would like to ask for an offer, let us know and we'll get back to you very soon.